BUSINESS● LOW2h ago · Sep 21, 2026, 4:20 AM
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
CNBC · global
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowAir Sénégal: how long can the state maintain its infusion?Jeune AfriqueBUSINESS26m agoMoniepoint MfB, TeamApt expand retail access to Dangote Refinery IPOVanguard Nigeria